Boston Scientific Approves 2026 Global Restructuring Program; Plan Intends To Cut Headcount; Expects ~$700M - $800M As Pre-Tax Charges; Plan Expected To Reduce Annual Pre-Tax Expenses by $500M

Benzinga News-desk www.benzinga.com Neutral 93.3%

Neg 0% Neu 93.3% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/885725/000088572526000049/bsx-20260721.htm

Comments

No comments yet. Be the first!